Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

NDRG4 Inhibitors

NDRG4, or N-Myc downstream-regulated gene 4, is a protein involved in various cellular processes, including cell differentiation, growth, and stress responses. It belongs to the NDRG family, which plays critical roles in regulating cell proliferation and differentiation. Specifically, NDRG4 is implicated in neuronal development, with its expression observed in various regions of the brain, suggesting its importance in neural function and development. Studies have also linked NDRG4 to tumor suppression in certain cancers, indicating its multifaceted roles in cellular homeostasis and disease pathology. Inhibition of NDRG4 activity can occur through various mechanisms, including modulation of its transcription, post-translational modifications, and interactions with other proteins or signaling pathways. One mechanism involves interference with the upstream signaling pathways that regulate NDRG4 expression or activity. For example, inhibition of key signaling pathways such as PI3K/Akt or MAPK can indirectly downregulate NDRG4 expression, thereby affecting its cellular functions. Additionally, direct targeting of NDRG4 protein stability or activity through small molecule inhibitors or RNA interference strategies could be explored to achieve specific inhibition. By understanding the intricate regulatory mechanisms of NDRG4 and its functional significance in various cellular contexts, researchers can devise targeted approaches to inhibit its activity for interventions in diseases where NDRG4 dysregulation is implicated.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin inhibits PI3K, a kinase involved in signaling pathways that can modulate the function of NDRG4.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is another PI3K inhibitor, which can alter downstream effects, possibly affecting NDRG4 activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an inhibitor of MEK, which is part of the MAPK/ERK pathway that can regulate NDRG4 expression.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 also targets MEK1/2 and can indirectly affect signaling pathways involving NDRG4.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 inhibits p38 MAPK, potentially altering stress response pathways that NDRG4 may be a part of.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor that can influence cellular processes related to NDRG4 activity.

NF449

627034-85-9sc-478179
sc-478179A
sc-478179B
10 mg
25 mg
100 mg
$203.00
$469.00
$1509.00
1
(0)

NF449 is a potent Gs-alpha inhibitor that indirectly affects signaling pathways associated with NDRG4 function.

CCG-1423

285986-88-1sc-205241
sc-205241A
1 mg
5 mg
$30.00
$90.00
8
(1)

CCG-1423 inhibits RhoA transcriptional signaling that might impact NDRG4-related cellular responses.

Gö 6976

136194-77-9sc-221684
500 µg
$227.00
8
(1)

Gö6976 is a potent protein kinase C inhibitor that may affect NDRG4 through modulation of intracellular signaling.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

BAPTA-AM is a calcium chelator that can influence calcium-dependent pathways related to NDRG4 function.